ONCR Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 17.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Oncorus Share Price & Price History
Current Price: $0.13
Price Change: +0.30 (1.20%)
As of 12/29/2023 01:00 AM ET
Oncorus Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/29/2022 | James E Flynn | Major Shareholder | Sell | 141,753 | $0.26 | $36,855.78 | 299,917 | |
| 12/27/2022 | James E Flynn | Major Shareholder | Sell | 65,090 | $0.27 | $17,574.30 | 321,551 | |
| 12/21/2022 | James E Flynn | Major Shareholder | Sell | 13,800 | $0.30 | $4,140.00 | 329,596 | |
| 12/19/2022 | James E Flynn | Major Shareholder | Sell | 99,718 | $0.29 | $28,918.22 | 332,725 | |
| 12/15/2022 | James E Flynn | Major Shareholder | Sell | 3,089 | $0.39 | $1,204.71 | 343,655 | |
| 12/13/2022 | James E Flynn | Major Shareholder | Sell | 2,097 | $0.41 | $859.77 | 344,937 | |
Oncorus Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 4/28/2023 | SG Americas Securities LLC | 126,525 | $44K | 0.0% | +74.1% | 0.485% |  |
| 10/12/2022 | Sawtooth Solutions LLC | 36,748 | $31K | 0.0% | -52.5% | 0.142% |  |
| 7/19/2022 | Sawtooth Solutions LLC | 77,336 | $97K | 0.0% | +22.9% | 0.299% |  |
| 7/13/2022 | Private Advisor Group LLC | 81,304 | $0.10M | 0.0% | +28.9% | 0.314% |  |
| 5/11/2022 | Letko Brosseau & Associates Inc. | 59,150 | $0.11M | 0.0% | +139.0% | 0.229% |  |
| 2/14/2022 | PDT Partners LLC | 31,191 | $0.16M | 0.0% | N/A | 0.121% |  |
| 2/14/2022 | Perceptive Advisors LLC | 999,812 | $5.27M | 0.1% | -9.1% | 3.874% |  |
| 2/14/2022 | Deep Track Capital LP | 600,000 | $3.16M | 0.2% | N/A | 2.325% |  |
| 2/11/2022 | Ensign Peak Advisors Inc | 38,000 | $0.20M | 0.0% | -49.3% | 0.147% |  |
| 2/10/2022 | Acadian Asset Management LLC | 10,338 | $54K | 0.0% | N/A | 0.040% |  |
| 2/8/2022 | Mirae Asset Global Investments Co. Ltd. | 189,115 | $1.02M | 0.0% | +30.4% | 0.733% |  |
| 2/7/2022 | SG Americas Securities LLC | 41,004 | $0.22M | 0.0% | -14.3% | 0.159% |  |
| 12/3/2021 | Perceptive Advisors LLC | 1,099,810 | $10.27M | 0.1% | -24.9% | 4.261% |  |
| 11/17/2021 | Altium Capital Management LP | 192,054 | $1.79M | 0.4% | N/A | 0.744% |  |
| 11/16/2021 | Janus Henderson Group PLC | 81,030 | $0.76M | 0.0% | -72.3% | 0.314% |  |
| 11/16/2021 | CHI Advisors LLC | 1,755,979 | $16.40M | 4.8% | +1.2% | 6.804% |  |
| 11/16/2021 | Citadel Advisors LLC | 1,882,510 | $17.58M | 0.0% | -1.0% | 7.294% |  |
| 11/15/2021 | Sphera Funds Management LTD. | 880,702 | $8.23M | 0.7% | -1.4% | 3.412% |  |
| 11/15/2021 | Sectoral Asset Management Inc | 361,821 | $3.38M | 0.3% | +8.0% | 1.402% |  |
| 11/12/2021 | Trexquant Investment LP | 26,028 | $0.24M | 0.0% | +84.5% | 0.101% |  |
| 11/12/2021 | Prosight Management LP | 55,411 | $0.52M | 0.3% | +10.8% | 0.215% |  |
| 11/12/2021 | Geode Capital Management LLC | 221,601 | $2.07M | 0.0% | -10.8% | 0.859% |  |
| 11/10/2021 | Goldman Sachs Group Inc. | 77,611 | $0.73M | 0.0% | -53.5% | 0.301% |  |
| 11/9/2021 | BlackRock Inc. | 1,105,449 | $10.32M | 0.0% | -0.2% | 4.283% |  |
| 11/4/2021 | Deutsche Bank AG | 182,849 | $1.71M | 0.0% | -60.4% | 0.710% |  |
| 11/2/2021 | New York State Common Retirement Fund | 12,325 | $0.12M | 0.0% | -29.8% | 0.048% |  |
| 11/1/2021 | SG Americas Securities LLC | 47,851 | $0.45M | 0.0% | +39.5% | 0.186% |  |
Data available starting January 2016
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Andover, Massachusetts.
Read More on Oncorus
Volume
135,947 shs
Average Volume
1,333,593 shs
Market Capitalization
$3.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
3.6